Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) on Thursday stated that the company turned to loss in the full-year 2018.
Net losses reached AED 153 million in 2018, against a profit worth AED 90.3 million in 2017, the company said in a statement to the Abu Dhabi Securities Exchange (ADX).
Earnings per share (EPS) recorded AED 12.8 for the year ended 31 December 2018, compared to AED 8.4 in the same period a year earlier.
Revenues of the UAE-based company hit AED 862.8 million in 2018, versus AED 1.273 billion in 2017.
By the end of Thursday’s session, Julphar’s stock went down 1.16% at AED 1.7.
